The Global Interstitial Lung Disease (ILD) Market is estimated to be valued at US$ 1578.9 million in 2021 and is expected to exhibit a CAGR of 6% during the forecast period (2022-2028). Interstitial lung disease (ILD) is a term used for a group of disorders that cause scarring (fibrosis) in the lungs. These scars cause stiffness in the lungs, making breathing difficult […]